Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis

PURPOSE: Although pirfenidone (PFD) is a key drug for the treatment of idiopathic pulmonary fibrosis (IPF), differences in tolerability between elderly and young patients remain unclear. This study aimed to investigate age-related differences in adverse drug reactions to PFD and to evaluate whether...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Sakayori, Masashi, Terada, Jiro, Abe, Mitsuhiro, Hirasawa, Yasutaka, Suzuki, Kenichi, Yoshioka, Keiichiro, Tsushima, Kenji, Tatsumi, Koichiro
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6630358/
https://ncbi.nlm.nih.gov/pubmed/31371923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S208733
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados